PFIZER INC (PFE) Stock Price, Quote, News and Overview
NYSE:PFE - New York Stock Exchange, Inc. - US7170811035 - Common Stock - Currency: USD
PFE Quote, Performance and Key Statistics
22.04
-0.4 (-1.78%)
The current stock price of PFE is 22.04 USD. In the past month the price decreased by -15.91%. In the past year, price decreased by -15.23%.
PFE Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 56.53 | 696.68B | ||
| JNJ | JOHNSON & JOHNSON | 15.31 | 370.90B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 18.23 | 279.13B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.8 | 216.43B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 16.16 | 207.88B | ||
| MRK | MERCK & CO. INC. | 10.01 | 192.40B | ||
| SNY | SANOFI-ADR | 11.34 | 123.77B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 43.3 | 100.44B | ||
| GSK | GSK PLC-SPON ADR | 8.17 | 71.74B | ||
| ZTS | ZOETIS INC | 24.79 | 65.46B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 31.85 | 46.28B | ||
| HLN | HALEON PLC-ADR | 21.17 | 45.87B |
Related stock screener links
About PFE
Company Profile
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The company is headquartered in New York City, New York and currently employs 81,000 full-time employees. The firm is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment is engaged in the science-based biopharmaceutical business. Its Biopharma segment includes the Pfizer Oncology Division, the Pfizer U.S. Commercial Division, and the Pfizer International Commercial Division. Its product categories include oncology, primary care and specialty care. Its Oncology products include Ibrance, Xtandi, Inlyta, Bosulif, Lorbrena, Braftovi, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio and Tivdak. Its primary care products include Eliquis, Nurtec ODT/Vydura, Comirnaty, the Prevnar family, Abrysvo, FSME/IMMUN-TicoVac, Paxlovid and Lucira by Pfizer. Its specialty care products include Xeljanz, Enbrel (outside the U.S. and Canada), Inflectra, Cibinqo, Litfulo, Vyndaqel family, Genotropin, Sulperazon, Zavicefta, Medrol and Panzyga.
Company Info
PFIZER INC
66 Hudson Boulevard East
New York City NEW YORK 10017 US
CEO: Albert Bourla
Employees: 81000
Company Website: https://www.pfizer.com/
Investor Relations: https://investors.pfizer.com
Phone: 12127332323
PFIZER INC / PFE FAQ
What is the stock price of PFIZER INC today?
The current stock price of PFE is 22.04 USD. The price decreased by -1.78% in the last trading session.
What is the ticker symbol for PFIZER INC stock?
The exchange symbol of PFIZER INC is PFE and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is PFE stock listed?
PFE stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for PFIZER INC stock?
27 analysts have analysed PFE and the average price target is 31.48 USD. This implies a price increase of 42.84% is expected in the next year compared to the current price of 22.04. Check the PFIZER INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is PFIZER INC worth?
PFIZER INC (PFE) has a market capitalization of 125.00B USD. This makes PFE a Large Cap stock.
How many employees does PFIZER INC have?
PFIZER INC (PFE) currently has 81000 employees.
What are the support and resistance levels for PFIZER INC (PFE) stock?
PFIZER INC (PFE) has a resistance level at 25.77. Check the full technical report for a detailed analysis of PFE support and resistance levels.
Is PFIZER INC (PFE) expected to grow?
The Revenue of PFIZER INC (PFE) is expected to decline by -0.05% in the next year. Check the estimates tab for more information on the PFE EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy PFIZER INC (PFE) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of PFE, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of PFE, evaluating the profitability, health, valuation and growth aspects
- PFIZER INC (PFE) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- PFIZER INC (PFE) Sales and EPS estimates to see what analysts future expectations are.
- PFIZER INC (PFE) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- PFIZER INC (PFE) Insider and Institutional Ownership to learn about the owners and their transactions.
- PFIZER INC (PFE) Stock Chart to make your own analysis
- PFIZER INC (PFE) Latest news and press-releases to stay up to date.
Does PFIZER INC (PFE) stock pay dividends?
PFIZER INC (PFE) has a dividend yield of 7.97%. The yearly dividend amount is currently 1.68. Check the full fundamental report for a detailed analysis of PFE dividend history, reliability and sustainability.
When does PFIZER INC (PFE) report earnings?
PFIZER INC (PFE) will report earnings on 2025-04-29, before the market open.
What is the Price/Earnings (PE) ratio of PFIZER INC (PFE)?
The PE ratio for PFIZER INC (PFE) is 7.09. This is based on the reported non-GAAP earnings per share of 3.11 and the current share price of 22.04 USD. Check the full fundamental report for a full analysis of the valuation metrics for PFE.
What is the Short Interest ratio of PFIZER INC (PFE) stock?
The outstanding short interest for PFIZER INC (PFE) is 1.68% of its float. Check the ownership tab for more information on the PFE short interest.
PFE Technical Analysis
PFE Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to PFE. While PFE belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health.
PFE Financial Highlights
Over the last trailing twelve months PFE reported a non-GAAP Earnings per Share(EPS) of 3.11. The EPS increased by 69.95% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 12.62% | ||
| ROA | 3.76% | ||
| ROE | 9.11% | ||
| Debt/Equity | 0.69 |
PFE Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 71% to PFE. The Buy consensus is the average rating of analysts ratings from 27 analysts.
For the next year, analysts expect an EPS growth of -3.92% and a revenue growth -0.05% for PFE